Biotech, Financing, M&A

Vivus rumored to be acquired by Aspen Investment

Posted on 03 June 2014

Tags: ,

Vivus is the subject of a buyout rumor for $640 million.

It is being reported that Aspen Investments, which could have an almost 10% stake in Vivus already, is set to offer $640 million for Vivus.

It is said that the offer will be conditional and non-binding.

It is anticipated that the offer will be submitted to the Vivus Board of Directors by June 13, 2014.

There are several things here for investors to consider.

First and foremost is that an offer has not yet been made.

At the moment, all that we have for information is that Aspen Investment is considering the submission of an offer.

For further deal information visit Current Agreements (subscription required)

Related

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply